SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-16-011085
Filing Date
2016-02-19
Accepted
2016-02-19 15:36:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDED SCHEDULE 13G sc13g0219a1cfwood_thera.htm SC 13G/A 70539
  Complete submission text file 0001213900-16-011085.txt   72144
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88552 | Film No.: 161441710
SIC: 2834 Pharmaceutical Preparations

Mailing Address 40 DUKES PLACE LONDON X0 EC3A 7NH
Business Address 40 DUKES PLACE LONDON X0 EC3A 7NH 0044 845922 0044
CF Woodford Equity Income Fund (Filed by) CIK: 0001637243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A